HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jane N Winter Selected Research

Hematopoietic Stem Cell Transplantation

11/2013Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial.
11/2009Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.
7/2007Defining the role of immunotherapy and radioimmunotherapy in the treatment of low-grade lymphoma.
1/2006Radioimmunotherapeutic strategies in autologous hematopoietic stem-cell transplantation for malignant lymphoma.
10/2004Combining yttrium 90-labeled ibritumomab tiuxetan with high-dose chemotherapy and stem cell support in patients with relapsed non-Hodgkin's lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jane N Winter Research Topics

Disease

31Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2022 - 06/2006
22Neoplasms (Cancer)
11/2021 - 10/2004
19Lymphoma (Lymphomas)
01/2021 - 01/2004
16Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2019 - 06/2003
10Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2020 - 07/2005
9Hodgkin Disease (Hodgkin's Disease)
11/2021 - 07/2005
5Disease Progression
03/2015 - 07/2005
4B-Cell Lymphoma (Lymphoma, B Cell)
11/2020 - 01/2006
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
05/2014 - 01/2006
3Thrombocytopenia (Thrombopenia)
10/2013 - 04/2010
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2021 - 05/2009
2Neutropenia
01/2020 - 10/2013
2Febrile Neutropenia
01/2020 - 06/2007
2Pancytopenia
02/2016 - 05/2009
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
07/2009 - 05/2004
1Critical Illness (Critically Ill)
04/2022
1COVID-19
04/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2015
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2015
1Genetic Translocation (Chromosomal Translocation)
10/2014
1B-Cell Leukemia (Leukemia, B Cell)
06/2014
1Pancreatitis
05/2014
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
10/2013
1Hematologic Neoplasms (Hematological Malignancy)
01/2013

Drug/Important Bio-Agent (IBA)

29Rituximab (Mabthera)FDA Link
01/2020 - 10/2007
10Vincristine (Oncovin)FDA LinkGeneric
01/2019 - 04/2006
9Proteins (Proteins, Gene)FDA Link
11/2021 - 06/2006
9Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 07/2005
7Prednisone (Sone)FDA LinkGeneric
01/2019 - 11/2012
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2019 - 11/2012
6Biological ProductsIBA
01/2022 - 03/2015
5Bortezomib (Velcade)FDA Link
01/2020 - 03/2013
4Monoclonal AntibodiesIBA
11/2021 - 07/2007
3Vinblastine (Vinblastine Sulfate)FDA Link
10/2018 - 07/2005
3Dacarbazine (DIC)FDA LinkGeneric
10/2018 - 07/2005
3AntigensIBA
12/2016 - 07/2007
3Bleomycin (Blenoxane)FDA LinkGeneric
02/2012 - 07/2005
3keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA
07/2011 - 06/2009
3Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
07/2011 - 06/2009
3ibritumomab tiuxetan (Zevalin)FDA Link
10/2009 - 10/2004
2DNA (Deoxyribonucleic Acid)IBA
03/2022 - 03/2007
2Immunoglobulin G (IgG)IBA
11/2021 - 06/2014
2Etoposide (VP 16)FDA LinkGeneric
01/2019 - 05/2004
2Brentuximab VedotinIBA
10/2018 - 05/2014
2MicroRNAs (MicroRNA)IBA
06/2015 - 07/2009
2Antineoplastic Agents (Antineoplastics)IBA
05/2014 - 10/2009
2Arsenic Trioxide (Trisenox)FDA Link
01/2013 - 08/2010
2Colony-Stimulating Factors (Colony Stimulating Factor)IBA
07/2011 - 02/2010
1Hemoglobins (Hemoglobin)IBA
04/2022
1RNA (Ribonucleic Acid)IBA
03/2022
1pembrolizumabIBA
11/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1selinexorIBA
11/2020
1Lenalidomide (CC 5013)FDA Link
01/2020
1Bendamustine HydrochlorideFDA Link
01/2020
1GSK-2816126IBA
12/2019
1Enhancer of Zeste Homolog 2 ProteinIBA
12/2019
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
10/2019
1IgKIBA
10/2019
1LigandsIBA
01/2019
1NF-kappa B (NF-kB)IBA
12/2016
1Prednisolone (Predate)FDA LinkGeneric
09/2016
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
02/2016
1SurvivinIBA
10/2015
1Inhibitor of Apoptosis ProteinsIBA
10/2015
1Chemokine ReceptorsIBA
03/2015
1Hydroxyurea (Hydrea)FDA LinkGeneric
03/2015
1Alemtuzumab (Campath)FDA Link
02/2015
1Codon (Codons)IBA
01/2015
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
10/2014
1carboxyl radical (COO-)IBA
10/2014
1Biomarkers (Surrogate Marker)IBA
10/2014
14-trifluoromethylsalicylic acid (HTB)IBA
08/2014
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
06/2014
1Cyclin D1IBA
06/2014
1dacetuzumabIBA
06/2014
1EverolimusFDA Link
05/2014
1pidilizumabIBA
11/2013
1GemcitabineFDA Link
10/2013
13' Untranslated Regions (3' UTR)IBA
05/2013
1NucleotidesIBA
05/2013
1Cytotoxins (Cytolysins)IBA
01/2013
1Pharmaceutical PreparationsIBA
01/2013
1Immunoglobulin Idiotypes (Idiotype, Immunoglobulin)IBA
07/2011
1Immunoglobulins (Immunoglobulin)IBA
07/2011
1Glutathione (Reduced Glutathione)IBA
08/2010
1Immunoconjugates (Immunoconjugate)IBA
04/2010

Therapy/Procedure

18Therapeutics
01/2020 - 06/2003
15Drug Therapy (Chemotherapy)
12/2021 - 06/2003
8Stem Cell Transplantation
01/2019 - 07/2005
6Immunotherapy
12/2021 - 07/2007
5Hematopoietic Stem Cell Transplantation
11/2013 - 10/2004
5Radioimmunotherapy
07/2010 - 10/2004
4Autologous Transplantation
01/2019 - 04/2009
4Radiotherapy
07/2014 - 07/2005
2Lymphatic Irradiation
01/2019 - 06/2014
2Treatment Delay
01/2018 - 10/2013
2VAP-cyclo protocol
10/2015 - 04/2006
1Transplantation
10/2013
1Induction Chemotherapy
07/2010